Approved Protocols
Section 1: General Treatment
Section 2: Trauma and Environmental Emergencies
Section 3: Adult Treatment Protocols
Section 4: Obstetrics and Pediatrics
Section 5: Adult Cardiac
Section 6: Pediatric Cardiac
Section 7: Procedures
- 12 Lead ECG
- ABUSE AND NEGLECT (SUSPECTED)
- BASIC EMT EPINEPHRINE INJECTION PROCEDURE
- CONTAMINATED PATIENT
- CPAP BIPAP ADMINISTRATION (OPTIONAL)
- CRIME SCENE MANAGEMENT
- DEAD ON SCENE
- DO NOT RESUSCITATE
- ELECTRICAL THERAPY
- EMERGENCY AIRWAY (Supplement) LMA Supreme
- EMERGENCY AIRWAY
- END TIDAL CARBON DIOXIDE MONITORING CAPNOMETRY AND CAPNOGRAPHY
- IMPEDANCE THRESHOLD DEVICE (ITD) (OPTIONAL)
- INJURED ATHLETE HELMET REMOVAL
- NASAL INTUBATION PROCEDURE SUPPLEMENT (OPTIONAL)
- OXYGEN ADMINISTRATION
- PAIN MANAGEMENT
- PATIENT ASSESSMENT
- PATIENT CARE RECORD, ELECTRONIC DOCUMENTATION EMS INFORMATION SYSTEM
- PATIENT RESTRAINT
- PATIENT SEDATION
- PLEURAL DECOMPRESSION
- REFUSAL OF CARE ADULT AND MINOR
- SPINAL PRECAUTIONS
- TERMINATION OF RESUSCITATION
- TERMINATION OF RESUSCITATION BLS
- TOURNIQUET APPLICATION
- VASCULAR ACCESS IV FLUID THERAPY
Section 8: System
- ALS TO BLS
- AMBULANCE TRANSPORT OF OPERATIONAL CANINES
- CANCELLATION DOWNGRADE OF CALL
- COMMUNICABLE DISEASE
- COMMUNICATIONS FAILURE
- COMPLAINT INVESTIGATION RESOLUTION
- CRITERIA FOR SERVICE ENDORSEMENT FOR OPERATION
- DEATH IN AN AMBULANCE AND TRANSPORT OF BODY
- DISPATCH
- DUE PROCESS AND DISCIPLINARY PROCEDURE
- EMERGENCY FACILITY REROUTING
- EMERGENCY MEDICAL DISPATCH
- EVIDENTIARY BLOOD DRAW (OPTIONAL)
- GUIDELINES FOR TRANSPORTATION OF PATIENTS SCENE TIMES
- HEALTH INSURANCE PORTABILITY ACCOUNTABILITY ACT (HIPAA)
- HELICOPTER UTILIZATION
- INCIDENT CLASSIFICATION
- INFECTION CONTROL
- INTERCEPT POLICY (OPTIONAL FOR ALL ALS SYSTEMS)
- LEFT VENTRICULAR ASSIST DEVICES
- LICENSURE LEVEL REQUIREMENT OF ATTENDANT DURING TRANSPORT (OPTIONAL)
- LIGHTS AND SIRENS RESPONSE TO THE SCENE
- MEDICAL CONTROL PRIVILEGES
- MEDICAL DIRECTION
- NEW LIFE SUPPORT AGENCY APPROVAL PROCESS
- PATIENT PRIORITIZATION
- PHYSICIAN ON SCENE
- PROFESSIONAL STANDARDS REVIEW ORGANIZATION (PSRO) STRUCTURE AND OPERATIONAL POLICY S
- PROTOCOL DEVIATION
- QUALITY IMPROVEMENT PROGRAM
- RESPONSIBILITIES OF THE PARTICIPANTS IN THE MEDICAL CONTROL AUTHORITY SYSTEM
- SAFE DELIVERY OF NEWBORNS
- TASER REMOVAL
- TRANSFER OF CARE
- TRANSFER OF PATIENT CARE BETWEEN EMS PROVIDERS AND RECEIVING FACILITIES
- USE OF EMERGENCY LIGHTS AND SIRENS DURING TRANSPORT
- UTILIZATION OF ECHO UNITS
- VIOLENT CHEMICAL HAZARDOUS SCENE
- WAIVER OF EMS PATIENT SIDE COMMUNICATION CAPABILITIES
Section 9: Medications
- ACETAMINOPHEN
- ACETYLSALICYLIC ACID (ASPIRIN)
- ADENOSINE
- ALBUTEROL (VENTOLIN ®)
- AMIODARONE
- ATROPINE
- CALCIUM CHLORIDE
- CYANOKIT ® (HYDROXOCOBALAMIN)
- D50 SHORTAGE PROTOCOL
- DEMCA Equipment Exchange
- DEXTROSE
- DIPHENHYDRAMINE
- EPINEPHRINE
- EPINEPHRINE AUTO INJECTOR PROCEDURE
- FENTANYL
- INTRANASAL MEDICATION ADMINISTRATION (OPTIONAL)
- IPRATROPIUM BROMIDE (ATROVENT ®)
- IV ANCILLARY SUPPLY EXCHANGE
- KETAMINE
- KETOROLAC (TORADOL ®)
- LIDOCAINE
- LORAZEPAM (ATIVAN ®)
- MAGNESIUM SULFATE
- MEDICATION ADMINISTRATION
- MEDICATION EXCHANGE AND REPLACEMENT PROCEDURE
- MEDICATION SHORTAGE
- MEDICATION SUBSTITUTION
- METHYLPREDNISOLONE
- MFR BLS MEDICATION KITS CONTENTS AND EXCHANGE PROCEDURE
- MIDAZOLAM (VERSED ®)
- MORPHINE
- NALOXONE (NARCAN ®)
- NALOXONE (NARCAN) ADMINISTRATION
- NEBULIZED BRONCHODILATORS
- NITROGLYCERIN
- ONDANSETRON (ZOFRAN ®)
- PROTOPAM CHLORIDE PRALIDOXIME
- PREDNISONE
- SODIUM BICARBONATE (NaHCO3)
Section 10: Special Operations
- CHEMICAL EXPOSURE
- CHEMPACK MEDDRUN
- CYANIDE EXPOSURE
- EMS IMMUNIZATION TB TESTING
- GENERAL CBRNE IDENTIFICATION OF AGENTS
- MASS CASUALTY INCIDENTS
- NERVE AGENT ORGANOPHOSPHATE PESTICIDE EXPOSURE TREATMENT
- PRE HOSPITAL (EMS) MCA MUTUAL AID AGREEMENT
- SPECIAL PATHOGEN RESPONSE NETWORK (SPRN) AMBULANCE CLEANING AND DISINFECTION (Optional)
- SPECIAL PATHOGEN RESPONSE NETWORK (SPRN) MEDICAL ISOLATION TRANSPORT DEVICE (OPTIONAL)
- SPECIAL PATHOGEN RESPONSE NETWORK (SPRN) PATIENT CARE DURING TRANSPORT OF SUSPECTED HIGHLY INFECTIOUS AGENT (Optional)
- SPECIAL PATHOGEN RESPONSE NETWORK (SPRN) PATIENT CONTAINMENT ALGORITHM (Optional)
- SPECIAL PATHOGEN RESPONSE NETWORK (SPRN) TEAM SELECTION PROCEDURE (Optional)
- SPECIAL PATHOGEN RESPONSE NETWORK (SPRN) TRANSPORT AND DESTINATION GUIDELINES (Optional)
- SPECIAL PATHOGEN RESPONSE NETWORK (SPRN) TRANSPORT PROCEDURE (Optional)
- SPECIAL PATHOGEN RESPONSE NETWORK (SPRN) TRANSPORT SUPPLIES (Optional)
- SUSPECTED PANDEMIC INFLUENZA
Destination Matrix
Section 14 COVID-19 Emergency Protocols Updated 4/1/21
Staffing-During-COVID-Pandemic-11.6.2020.pdf
IMMUNIZATION SUPPORT DURING COVID 19 OUTBREAK
14.09-COVID-19-Treat-in-Place-Final 11.17.2020
NCoV Specimen Collection Final 3.20.2020
NCoV Destination Protocol Revision 3.20.2020
NCoV Resuscitation Final 3.23.2020
NCoV Clinical Treatment 3.23.2020
DEMCA Emergency COVID Transportation Guidelines.docx
14.04 Conventional Response During COVID 19 Outbreak 12.21.2020
14.13 NCoV Monoclonal Antibodies Final 3.26.21
DEMCA BVM COVID-19 Policy